Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy
出版年份 2012 全文链接
标题
Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 12, Issue sup1, Pages S217-S224
出版商
Informa Healthcare
发表日期
2012-05-24
DOI
10.1517/14712598.2012.689280
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lung cancer biomarkers – Where we are and what we need
- (2017) Petra Stieber et al. Cancer Biomarkers
- Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
- (2012) Yvonne Nadine Fahmueller et al. BMC CANCER
- Tumor response assessments with diffusion and perfusion MRI
- (2012) Sonia P. Li et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Tumor-Cell Death, Autophagy, and Immunity
- (2012) Louis M. Weiner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
- (2011) Nikolaus Kohles et al. BMC CANCER
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- HMGB1 and RAGE in Inflammation and Cancer
- (2010) Gary P. Sims et al. Annual Review of Immunology
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Plasma Nucleosome Levels Might Predict Response to Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Sachin Kumar et al. Clinical Lung Cancer
- HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
- (2010) D Tang et al. ONCOGENE
- Clinical Relevance of Circulating Nucleosomes in Cancer
- (2009) Stefan Holdenrieder et al. Annals of the New York Academy of Sciences
- The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
- (2009) R Kang et al. CELL DEATH AND DIFFERENTIATION
- Clinical use of circulating nucleosomes
- (2009) Stefan Holdenrieder et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Clinical Value of Serum HMGB1 Levels in Early Detection of Recurrent Squamous Cell Carcinoma of Uterine Cervix: Comparison with Serum SCCA, CYFRA21-1, and CEA Levels
- (2009) Xiugui Sheng et al. CROATIAN MEDICAL JOURNAL
- Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications
- (2009) A. Bierhaus et al. DIABETOLOGIA
- Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy.
- (2009) Wojciech Naumnik et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- HMGB1 loves company
- (2009) Marco E. Bianchi JOURNAL OF LEUKOCYTE BIOLOGY
- RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation
- (2009) Louis J Sparvero et al. Journal of Translational Medicine
- Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer
- (2009) Guan-Hong Shang et al. RESPIRATORY MEDICINE
- Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update
- (2008) S. H. Beachy et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies
- (2008) L. Apetoh et al. CANCER RESEARCH
- Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
- (2008) S. Holdenrieder et al. CLINICAL CANCER RESEARCH
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma
- (2008) B.-Q. Cheng et al. DIGESTIVE AND LIVER DISEASE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE
- (2008) Vilma Urbonaviciute et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nucleosomes and CYFRA 21-1 indicate tumor response after one cycle of chemotherapy in recurrent non-small cell lung cancer
- (2008) Stefan Holdenrieder et al. LUNG CANCER
- Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
- (2008) Vathany Kulasingam et al. Nature clinical practice. Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now